Invivyd (IVVD) Interest Coverage Ratio (QoQ) (2021 - 2025)
Invivyd (IVVD) Interest Coverage Ratio (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 397.58% |
| Sep 30, 2025 | 67.98% |
| Jun 30, 2025 | 50.56% |
| Mar 31, 2025 | -409.77% |
| Dec 31, 2024 | 119.07% |
| Sep 30, 2024 | -26.53% |
| Jun 30, 2024 | -8,067.17% |
| Mar 31, 2024 | -100.90% |
| Dec 31, 2023 | 811.18% |
| Sep 30, 2023 | 82.55% |
| Jun 30, 2023 | -127.26% |
| Mar 31, 2023 | 77.24% |
| Dec 31, 2022 | -3,023.58% |
| Sep 30, 2022 | -3.97% |
| Jun 30, 2022 | 21.94% |
| Mar 31, 2022 | 97.71% |
| Dec 31, 2021 | -403,408.68% |
| Sep 30, 2021 | 82.13% |
| Jun 30, 2021 | 99.85% |